NCM Boston | Oxford Nanopore Technologies
NCM Boston
NCM Boston
A
)
Alex KneubehlBaylor College of Medicine, USA
)
Anne-Sophie LebreCHU Reims, France
)
Ailsa MacCalmanUniversity of Exeter, UK
)
Anastasia McKinlayIndiana University & HHMI, USA
)
Ana PeresThe University of North Carolina at Chapel Hill, USA
)
Aaron VinyColumbia University Irving Medical Center, USA
)
)
)
)
)
)
)
J
)
Justin BeckerDana-Farber Cancer Institute & Massachusetts General Hospital, USA
)
Jack ColicchioSound Agriculture, USA
)
J. (Gus) GustafsonUniversity of Washington, USA
K
)
Karine ChoquetUniversity of Sherbrooke, Canada
)
Kamil KhanipovThe University of Texas Medical Branch, USA
L
)
Lucia DaxingerLeiden University Medical Center, Netherlands
)
Lantana GrubVanderbilt University, USA
)
Laura KamenetzkyCONICET, Argentina
)
)
)
)
)
)
)
Oxford Nanopore Technologies
Ela Sauerborn
)
- Job title
- Institution
- Helmholtz AI Institute Munich, Germany
- Biography
Ela Sauerborn is a clinical microbiologist in training at the TUM University Hospital Munich and is currently in the first year of a PhD (concurrent with clinical training) in Lara Urban's Genomics for One Health group at the Helmholtz AI Institute, focusing on nanopore sequencing for plasmid-mediated carbapenem resistance detection in a clinical context. In addition to her medical background, Ela holds an MSc in infectious disease epidemiology with a focus on mathematical modelling and a BA in social sciences.
- Recent publications
Sauerborn, E. et al. Detection of hidden antibiotic resistance through real-time genomics. Nat. Commun. 15, 5494 (2024).
DOI: 10.1038/s41467-024-49851-4